Building TRUST
建立信任
基本信息
- 批准号:9303238
- 负责人:
- 金额:$ 66.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-07-01 至 2020-06-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS preventionAdherenceAdoptedAdoptionAnti-Retroviral AgentsAnusAttitudeAwarenessBehavioralBeliefBiologicalBiological MarkersCaringChlamydiaClinicalCommunitiesDataDevelopmentDiagnosisDisclosureEgoEnrollmentEnvironmental Risk FactorEpidemicEpidemiologyFundingGoalsGonorrheaGovernmentGuidelinesHIVHIV InfectionsHIV SeropositivityHIV antiretroviralHairIncidenceIndividualInfectionInterventionKnowledgeLawsLegalLinkMeasurableMethodsModelingMolecularNigeriaOutcomePatternPerceptionPersonsPopulationPositioning AttributePrevalencePreventionPrevention approachPreventive InterventionProbabilityPublic HealthRefractoryResearch Project GrantsRespondentSamplingSequence AnalysisServicesSex OrientationSexual PartnersSexually Transmitted DiseasesSocial supportTreatment outcomeUnited States National Institutes of HealthViral Load resultWorld Health Organizationbasebehavior changebiobehaviorcohorteffective therapyepidemiological modelfollow-uphigh riskhigh risk menimplementation scienceimproved outcomeindexinginnovationinsightmenmen who have sex with menmen&aposs groupmodel buildingpre-exposure prophylaxispreventprogramspublic health relevancesocialsocial capitalsocial stigmatooltransmission processuptake
项目摘要
DESCRIPTION (provided by applicant): Building TRUST builds on insights gained from TRUST (1R01MH099001), an implementation science research grant that uncovered a high risk men who have sex with men (MSM) "hotspot" subcohort of highly marginalized men disproportionately represented in later waves of respondent-driven sampling (RDS)(applied as a public health implementation tool) with a high HIV prevalence (44%), low uptake of clinical engagement and treatment as prevention (TasP), low levels of disclosure of HIV and/or sexual orientation, high incidence rates of both HIV infection (13.9 per 100 person- years) and sexually transmitted infections (STI) (gonorrhea and chlamydia) indicative of unprotected anal intercourse, and ego-network data documenting high rates of risky sexual positioning and low rates of serosorting despite knowledge of HIV status. Building TRUST posits that within the treatment and prevention cascade, there are cascade-specific interpersonal, network and structural barriers amendable to targeted intervention(s) that can favorably impact measurable outcomes of efficiency. Building TRUST, framed in the 2014 WHO Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations especially biomedical prevention approaches, employs the Social Ecological Model (SEM) to longitudinally collect individual, interpersonal and environmental data targeting this "hotspot" cohort and integrates innovative phylodynamic modeling to gain fundamental insights about the drivers of ineffective prevention and treatment outcomes. The 3 aims of Building TRUST are: Specific Aim 1: Framed in the Social Ecologic Model, explore individual (e.g. disclosure), interpersonal (e.g. social/sexual network) and environmental (e.g. legalized stigma- antigay laws) to identify barriers and facilitators of effective engagement in the TasP cascade among HIV- infected MSM. Outcomes: A multidimensional understanding of barriers to effective engagement in TasP indexed by objective biomarkers (e.g. HIV viral load). Specific Aim 2: In the face of suboptimal uptake of behavior change among HIV-uninfected MSM, investigate the impact of introducing pre-exposure prophylaxis (PrEP) (newly adopted by the Government of Nigeria) at the individual (e.g. uptake), interpersonal (e.g. social support, sexual partner), and environmental (e.g. social capital and stigma) levels. Outcomes: A multidimensional understanding of barriers to effective engagement in PrEP indexed by objective biomarkers cross compared to data from Aim 1 to guide intervention strategies. Specific Aim 3: Characterize HIV transmission networks within the MSM community by applying phylodynamic epidemiological analyses linked to bio-behavioral and RDS and ego-network data from Aim 1 and among high-risk HIV-uninfected MSM, incident HIV infections from Aim 2 follow-up. Outcomes: Enhanced understanding of how HIV transmission occurs within and across MSM sexual networks leading to actionable interventions tailored to interdict forward transmission.
描述(由申请人提供):建立信任建立在从信任(1R01MH099001)获得的洞察力的基础上,这是一项实施科学研究拨款,发现了高度边缘化的男性的高危男性(MSM)“热点”亚队列,这些男性不成比例地出现在随后几波受访者驱动的抽样(RDS)(作为公共卫生实施工具)中,艾滋病毒感染率高(44%),临床参与和治疗作为预防(TasP)的接受度低,艾滋病毒和/或性取向的披露水平低,艾滋病毒感染(每100人年13.9人)和性传播感染(性病)(淋病和衣原体)的高发病率表明无保护的肛交,自我网络数据记录了高风险的性定位和低的血清吸毒率,尽管知道艾滋病毒的状况。建立信任假定,在治疗和预防级联中,存在级联特有的人际、网络和结构性障碍,可以通过有针对性的干预来修正(S),这些障碍可以有利地影响可衡量的效率结果。建立信任,框架在2014年世卫组织重点人群艾滋病毒预防、诊断、治疗和护理综合指南,特别是生物医学预防方法,利用社会生态模型(SEM)纵向收集针对这一“热点”队列的个人、人际和环境数据,并整合创新的系统动力学模型,以获得关于无效预防和治疗结果的驱动因素的基本见解。建立信任的3个目标是:具体目标1:在社会生态模型框架内,探索个人(例如披露)、人际(例如社会/性网络)和环境(例如合法化的污名-反同性恋法律),以确定在感染艾滋病毒的男男性行为者中有效参与TasP级联的障碍和促进者。结果:对以客观生物标记物(如艾滋病毒病毒载量)为指标的有效参与TasP的障碍有多方面的了解。具体目标2:面对未感染艾滋病毒的男男性行为者对行为改变的接受程度不佳,调查在个人(如感染)、人际(如社会支持、性伴侣)和环境(如社会资本和耻辱)层面引入暴露前预防措施(PrEP)的影响。结果:以客观生物标记物为索引的对有效参与PrEP的障碍的多维理解与来自Aim 1的数据相比较以指导干预策略。具体目标3:通过应用与来自目标1的生物行为和RDS以及自我网络数据相联系的系统动力学流行病学分析,描述男男性接触者社区内艾滋病毒传播网络的特征,以及来自目标2后续行动的未感染艾滋病毒的高危男男性行为者中的艾滋病毒感染事件。结果:加强了对艾滋病毒如何在MSM性网络内和跨性网络传播的理解,从而产生了可操作的干预措施,以阻断前向传播。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Manhattan E Charurat其他文献
Manhattan E Charurat的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Manhattan E Charurat', 18)}}的其他基金
Integrated Networks of Scholars in Global Health Research Training (INSIGHT) ODP supplement
全球卫生研究培训综合学者网络 (INSIGHT) ODP 补充
- 批准号:
10892423 - 财政年份:2023
- 资助金额:
$ 66.14万 - 项目类别:
Botswana Smoking Abstinence Reinforcement Trial (BSMART)
博茨瓦纳戒烟强化试验(BSMART)
- 批准号:
10705316 - 财政年份:2022
- 资助金额:
$ 66.14万 - 项目类别:
Integrated Networks of Scholars in Global Health Research Training (INSIGHT)
全球健康研究培训学者综合网络(INSIGHT)
- 批准号:
10589859 - 财政年份:2022
- 资助金额:
$ 66.14万 - 项目类别:
Integrated Networks of Scholars in Global Health Research Training (INSIGHT) ODSS supplement
全球卫生研究培训学者综合网络 (INSIGHT) ODSS 补充
- 批准号:
10874249 - 财政年份:2022
- 资助金额:
$ 66.14万 - 项目类别:
Botswana Smoking Abstinence Reinforcement Trial (BSMART)
博茨瓦纳戒烟强化试验(BSMART)
- 批准号:
10541071 - 财政年份:2022
- 资助金额:
$ 66.14万 - 项目类别:
Synergistic epidemics of non-communicable diseases, stigma, depression, and material insecurities among sexual and gender minorities living with HIV in Nigeria
尼日利亚艾滋病毒感染者中性少数群体和性别少数群体中非传染性疾病、耻辱、抑郁和物质不安全感的协同流行
- 批准号:
10674991 - 财政年份:2022
- 资助金额:
$ 66.14万 - 项目类别:
Integrated Networks of Scholars in Global Health Research Training (INSIGHT)
全球健康研究培训学者综合网络(INSIGHT)
- 批准号:
10473166 - 财政年份:2022
- 资助金额:
$ 66.14万 - 项目类别:
Synergistic epidemics of non-communicable diseases, stigma, depression, and material insecurities among sexual and gender minorities living with HIV in Nigeria
尼日利亚艾滋病毒感染者中性少数群体和性别少数群体中非传染性疾病、耻辱、抑郁和物质不安全感的协同流行
- 批准号:
10540034 - 财政年份:2022
- 资助金额:
$ 66.14万 - 项目类别:
Impact of Non - B HIV - 1 Subtype on second line Protease Inhibitor Regimens in Africa (INSPIRE)
非 B HIV-1 亚型对非洲二线蛋白酶抑制剂治疗方案的影响 (INSPIRE)
- 批准号:
10556406 - 财政年份:2020
- 资助金额:
$ 66.14万 - 项目类别:
相似海外基金
An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
- 批准号:
10057526 - 财政年份:2023
- 资助金额:
$ 66.14万 - 项目类别:
Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
- 批准号:
490105 - 财政年份:2023
- 资助金额:
$ 66.14万 - 项目类别:
Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
- 批准号:
2325465 - 财政年份:2023
- 资助金额:
$ 66.14万 - 项目类别:
Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
- 批准号:
10821172 - 财政年份:2023
- 资助金额:
$ 66.14万 - 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
- 批准号:
10766947 - 财政年份:2023
- 资助金额:
$ 66.14万 - 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
- 批准号:
10772887 - 财政年份:2023
- 资助金额:
$ 66.14万 - 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 66.14万 - 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
- 批准号:
10748465 - 财政年份:2023
- 资助金额:
$ 66.14万 - 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
- 批准号:
10591441 - 财政年份:2023
- 资助金额:
$ 66.14万 - 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
- 批准号:
491109 - 财政年份:2023
- 资助金额:
$ 66.14万 - 项目类别:
Fellowship Programs














{{item.name}}会员




